Back to search

Virginia Tech

Ambiguous Evidence: The Rhetorical Work of Interpreting Clinical Trial Evidence after the Women's Health Initiative

Abstract

dc:description.abstract

The early termination of the Women's Health Initiative (WHI) hormone therapy trial in 2002 significantly reshaped clinical discourse surrounding menopause treatment and the safety of hormone replacement therapy. Although the WHI was widely interpreted as evidence that hormone therapy increased risks such as breast cancer and cardiovascular disease, clinicians in medical journals quickly began deliberating how the trial's findings should be interpreted and applied to clinical care. This dissertation examines how clinicians reasoned about and interpreted WHI evidence during the early years following the trial's publication. Drawing on qualitative coding and rhetorical analysis of scientific discourse, this study applies a retroactive risk communication framework to analyze a corpus of twenty-seven editorials and review articles published in medical journals between 2002 and 2007. These genres are particularly influential spaces where clinicians interpret emerging evidence and guide professional understanding of clinical research for practice. Through this analysis, the study identifies how clinicians acknowledged methodological limitations in the WHI, including issues related to study design, participant population, and the generalizability of the trial's findings. Despite these critiques, clinicians did not dismiss the WHI as invalid evidence. Instead, they preserved the trial's authority and clinical utility of its' evidence using what this dissertation terms risk topoi. Risk topoi function as interpretive mechanisms that allow clinicians to narrow, reinterpret, or create conditions around trial findings to align them with existing clinical knowledge and patient care practices. By tracing how these risk topoi operate within clinical argumentation, this dissertation demonstrates how clinicians maintain the utility of large clinical trials even amid methodological uncertainty and debate. This study contributes to the scholarship of the rhetoric of health and medicine, technical communication, and science and technology studies by showing how clinical knowledge is produced not only through the generation of new evidence but also through the rhetorical work of interpreting and stabilizing that evidence within professional discourse.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Rhetoric and Writing
Department dc:contributor.department
English
Grantor dc:publisher
Virginia Tech
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Buccilli, Marissa
Chair dc:contributor.committeechair
  • Gerdes, Julie Marie
Committee members dc:contributor.committeemember
  • Commer, Carolyn
  • Pender, Kelly Elizabeth
  • Craig, Sherri Elaine

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Other
vt_gsexam:46191

Chain of custody

source
Harvested from
Virginia Tech
Base URL
vtechworks.lib.vt.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Buccilli, Marissa. Ambiguous Evidence: The Rhetorical Work of Interpreting Clinical Trial Evidence after the Women's Health Initiative. doctoral thesis, Virginia Tech, 2026. https://hdl.handle.net/10919/143473